Fatty liver disease (MASLD/MASH): open trials in South Korea

15 open trials have a site in South Korea. Registry data; only the trial team decides who can take part.

NCT06215716
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Trial Treatment · Phase 3 · Akero Therapeutics, Inc
Daegu · Goyang-si · Incheon · Seongnam-si · Seoul
Registry updated 2026-11-06
NCT06632444
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
Soon Chun Hyang University Hospital Bucheon, Bucheon-si · Pusan National University Hospital, Busan · Yeungnam University Medical Center, Deagu · Inha University Hospital, Incheon · Samsung Medical Center, Seoul · Seoul National University Hospital, Seoul · Chung ang University Hospital, Seoul · Asan Medical Center, Seoul · Korea University Guro Hospital, Seoul · SMG-SNU Boramae Medical Center, Seoul · Yonsei University Wonju Severance Christian Hospital, Wŏnju
Registry updated 2026-10-28
NCT06632457
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
Soon Chun Hyang University Hospital Bucheon, Bucheon-si · Pusan National University Hospital, Busan · Inha University Hospital, Incheon · Samsung Medical Center, Seoul · Chung ang University Hospital, Seoul · Seoul National University Hospital, Seoul · SMG-SNU Boramae Medical Center, Seoul · Korea University Guro Hospital, Seoul · Asan Medical Center, Seoul · Yonsei University Wonju Severance Christian Hospital, Wŏnju
Registry updated 2026-10-28
NCT06318169
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Trial Treatment · Phase 3 · Hoffmann-La Roche
Busan · Daegu · Gyeonggi-do · Incheon · Seoul
Registry updated 2026-10-23
NCT06419374
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Trial Treatment · Phase 3 · Hoffmann-La Roche
Bucheon-si · Busan · Daegu · Incheon · Seoul
Registry updated 2026-10-23
NCT06528314
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Trial Treatment · Phase 3 · Akero Therapeutics, Inc
Daegu · Goyang-si · Incheon · Seoul · Wŏnju
Registry updated 2026-10-13
NCT05519475
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Trial Treatment · Phase 2 · Regeneron Pharmaceuticals
Pusan National University Hospital, Busan · Keimyung University Dongsan Hospital, Daegu · Kyungpook National University Hospital, Daegu · Seoul National University Bundang Hospital, Seongnam-si · Hanyang University Seoul Hospital, Seoul
Registry updated 2026-10-08
NCT07165028
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Trial Treatment · Phase 3 · Eli Lilly and Company
Korea University Ansan Hospital, Ansan-si · Soon Chun Hyang University Bucheon Hospital, Bucheon-si · Pusan National University Yangsan Hospital, Busan · Yeungnam Univeristy Medical Center, Daegu · Keimyung University Dongsan Hospital, Daegu · Boramae Medical Center, Dongjak-gu · Chung-Ang University Hospital, Dongjak-gu · Hanyang University Guri Hospital, Guri-si · Inha University Hospital, Incheon · Gyeongsang National University Hospital, Jinju · Kyungpook National University Hospital, Junggu · Hanyang University Seoul Hospital, Seoul · The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul · Samsung Medical Center, Seoul · Seoul National University Hospital, Seoul · The Catholic University of Korea, Eunpyeong St. Mary's Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Asan Medical Center, Seoul · Wonju Severance Christian Hospital, Wŏnju
Registry updated 2026-10-08
NCT06519162
Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Research · Chungnam National University Hospital
Chungnam National University Hospita, Daejeon
Registry updated 2026-03-20
NCT06493799
In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop
Trial Treatment · Phase 3 · Green Cross Wellbeing
GC wellbeing, Yongin-si
Registry updated 2026-02-25
NCT06989723
Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes
Trial Treatment · Phase 4 · Seoul National University Bundang Hospital
Seoul National University Bundang Hospital, Seongnam-si
Registry updated 2025-05-25
NCT02206841
Establishment of NAFLD Cohort and Development of Fibrosis Markers
Research · Seoul National University Boramae Hospital
Seoul Metropolitan Government Seoul National University, Seoul
Registry updated 2025-05-15
NCT06843421
Korean Health Screening-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Registry
Research · Korea University
Wonju Severance Christian Hospital, Gangwon-do · Chung-Ang University Gwangmyeong Hospital, Gyeonggi-do · Inje Univerisity Sanggye Paik Hospital, Seoul · Ajou University Hospital, Suwon · Yonsei University Yongin Severance Hospital, Yongin
Registry updated 2025-02-27
NCT06649162
A Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination Therapy
Research · Boryung Pharmaceutical Co., Ltd
Andong Hospital, Andong · Konkuk University Medical Center, Seoul
Registry updated 2024-10-18
NCT06152991
Clinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for Efficacy
Trial Treatment · Phase 3 · Yoon Jun Kim
Seoul National University Hospital, Seoul
Registry updated 2023-12-01

All Fatty liver disease (MASLD/MASH) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error